Opko Health (NYSE:OPK) CEO Phillip Md Et Al Frost purchased 30,000 shares of the stock in a transaction dated Tuesday, July 8th. The shares were purchased at an average price of $8.58 per share, for a total transaction of $257,400.00. Following the completion of the transaction, the chief executive officer now directly owns 1,987,500 shares in the company, valued at approximately $17,052,750. Opko Health Inc. (NYSE:OPK) stock performance was 1.64% in last session and finished the day at $8.70. Traded volume was 2.02million shares in the last session and the average volume of the stock remained 2.50million shares. The beta of the stock remained 1.09. Opko Health Inc. (NYSE:OPK) insider ownership is 6.90%.

American Apparel Inc (NYSEMKT:APP) CEO Dov Charney bought 27,351,407 shares of American Apparel stock in a transaction that occurred on Friday, June 27th. The stock was purchased at an average cost of $0.72 per share, with a total value of $19,693,013.04. Following the acquisition, the chief executive officer now directly owns 74,560,813 shares in the company, valued at approximately $53,683,785. American Apparel Inc (NYSEMKT:APP) rose 1.12 percent to $0.850 Wednesday on volume of 3.47million shares. The intra-day range of the stock was $0.81 to $0.87. American Apparel Inc (NYSEMKT:APP)  has a market capitalization of $147.39million.

Accelerate Diagnostics (NASDAQ:AXDX) Director Jack W. Schuler purchased 8,698 shares of the company’s stock on the open market in a transaction dated Tuesday, July 1st. The shares were purchased at an average price of $25.70 per share, with a total value of $223,538.60. Accelerate Diagnostics Inc (NASDAQ:AXDX)’s stock on July 09, 2014 reported a increase of 1.98% to the closing price of $25.81. Its fifty two weeks range is $6.86 -$31.86. The total market capitalization recorded $1.15billion. The overall volume in the last trading session was 139,222.00million shares. In its share capital, AXDX has 44.58million outstanding shares.

Biota Pharmaceuticals (NASDAQ:BOTA) CEO Russell H. Plumb purchased 32,031 shares of the stock on the open market in a transaction that occurred on Wednesday, June 11th. The shares were purchased at an average price of $2.99 per share, for a total transaction of $95,772.69. Following the acquisition, the chief executive officer now directly owns 127,579 shares of the company’s stock, valued at approximately $381,461. On Wednesday, shares of Biota Pharmaceuticals Inc (NASDAQ:BOTA) advanced 2.39% to close the day at $3.00. Company return on investment (ROI) is -21.20% and its monthly performance is recorded as 23.97%. Biota Pharmaceuticals Inc (NASDAQ:BOTA) quarterly revenue growth is -47.09%.

Echo Therapeutics (NASDAQ:ECTE) major shareholder Mark Nordlicht acquired 65,739 shares of the company’s stock on the open market in a transaction that occurred on Monday, June 30th. The stock was purchased at an average price of $2.20 per share, for a total transaction of $144,625.80. Echo Therapeutics Inc (NASDAQ:ECTE) stock finished the day at $2.11. Traded volume was 55,225.00million shares in the last session and the average volume of the stock remained 108.87K shares. The beta of the stock remained 1.13. Echo Therapeutics Inc (NASDAQ:ECTE) insider ownership is 0.10%.